aprepitant - Compound Summary (CID 151165)
Also known as: Emend, Aprepitant [USAN], MK 869, UNII-1NF15YR6UY, AC1L45SL, MK 0869, L 754030, DB00673, NCGC00181785-01
Molecular Formula: C23H21F7N4O3   Molecular Weight: 534.426662   InChIKey: ATALOFNDEOCMKK-BYYRLHKVSA-N
Aprepitant, an antiemetic, is a substance P/neurokinin 1 (NK1) receptor antagonist which, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy. Aprepitant is a selective high-affinity antagonist of human substance P/neurokinin 1 (NK1) receptors. Aprepitant has little or no affinity for serotonin (5-HT3), dopamine, and corticosteroid receptors, the targets of existing therapies for chemotherapy-induced nausea and vomiting (CI NV).   From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Use and Manufacturing
Pharmacology
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _